Form D · Biotechnology

NeuroOne, Inc.

Eden Prairie, MN · CIK 0001690435

Offering snapshot reported Jun 15, 2017 · SEC filing

Reported sold: $1.53M
Investors reported: 14
Minimum accepted: $50K
First sale: Nov 21, 2016

Fundraising history

Reported sold

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

Reported sold$700,000 → $1,525,120
Reported investors5 → 14

Filing history

Scroll to see all columns →

Filed	Filing type	Reported sold	Change vs linked filing	Investors	Source
Jun 15, 2017	Amendment	$1,525,120	$825,120vs Jan 5, 2017	14	SEC filing
Jan 5, 2017	Amendment	$700,000	$400,000vs Dec 5, 2016	5	SEC filing
Dec 5, 2016	Initial	$300,000	No comparison	2	SEC filing

Offering details

Securities: Debt, Option to acquire, Security to be acquired
Exemptions: 06b
Duration over one year: No
Business combination: No

Sales commissions: $120K (estimated)
Finders' fees: $0
Form D file number: 021-275642

Sales compensation recipients

Scroll to see all columns →

Recipient	CRD	Associated broker-dealer
Corinthian Partners, L.L.C.	38912

Source: Form D, filed Jun 15, 2017. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
Name	Reported role
Thomas Bachinski	Executive
Paul Buckman	Director
Mark Christianson	Executive
Wade Fredrickson	Executive
Suraj Kalia	Director
Jeff Mathiesen	Director
David A Rosa	Director, Executive
Dave A Rosa	Director, Executive

Issuer details

Industry: Biotechnology (See others in industry)

Address:

10006 Liatris Lane
Eden Prairie, MN, 55347